2025 年全球關節痛注射市場報告

預計未來幾年關節痛注射劑的市場規模將快速成長。到 2029 年，這一數字將成長至 98.1 億美元，複合年成長率為 12.3%。預測期內的成長可歸因於遠端醫療服務的擴展、個人化疼痛管理、病患教育和賦權、永續的醫療保健實踐和營養支持。預測期內的主要趨勢包括再生醫學、個人化疼痛管理、創新注射材料、復健技術和人工智慧（AI）增強注射。

關節炎和肌肉骨骼疾病的盛行率不斷上升預計將推動關節痛注射市場的成長。肌肉骨骼疾病是全球範圍內導致殘疾的主要原因，其中腰痛被確定為 160 個國家中最常見的殘疾原因。疼痛患者經常接受注射來緩解疼痛和控制發炎。例如，2023年6月，澳洲政府機構澳洲健康與福利研究所報告稱，類風濕性關節炎佔總疾病負擔的2.0%，佔與肌肉骨骼疾病相關的總疾病負擔的16%。 2022年死亡人數為1,322人，相當於每10萬人口5.1人死亡，佔全部死亡人數的0.7%。因此，關節炎和肌肉骨骼疾病盛行率的上升推動了關節痛注射市場的發展。

慢性疼痛盛行率的上升預計將推動關節痛注射市場未來的成長。慢性疼痛的特徵是長時間持續或持久的不適，一般定義為持續至少 3-6 個月或超過預期的癒合期。關節痛注射通常用於治療慢性疼痛，尤其是與肌肉骨骼疾病（如骨關節炎、類風濕性關節炎和其他關節相關疾病）相關的慢性疼痛。例如，2022年9月，世界衛生組織（WHO）在其2022年重點報告中報告，非傳染性疾病（NCD）或慢性病導致4,100萬人死亡，佔全球整體的74%。因此，慢性疼痛發生率的不斷增加正在推動關節痛注射市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球關節痛注射PESTEL分析（政治、社會、科技、環境、法律因素、促進因素、限制因素）
• 最終用途產業分析
• 全球關節疼痛注射市場成長率分析
• 全球關節痛注射市場表現：規模與成長，2019 年至 2024 年
• 全球關節痛注射市場預測：規模與成長，2024-2029 年，2034 年
• 全球關節痛注射劑總目標市場 (TAM)

第6章 市場細分

• 全球關節痛注射市場：按注射類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 類固醇關節注射
• 玻尿酸注射
• 富血小板血漿 (PRP) 注射
• 胎盤組織基質（PTM）注射
• 其他類型注射
• 全球關節痛注射市場：按關節類型、表現和預測，2019-2024 年、2024-2029 年、2034 年
• 髖關節
• 膝蓋和腳踝
• 肩膀和肘部
• 脊椎椎間關節
• 其他關節類型
• 全球關節痛注射市場：依通路、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 醫院藥房
• 零售藥局
• 網路藥局
• 全球關節痛注射市場：類固醇關節注射細分市場、注射類型、效能和預測，2019-2024 年、2024-2029 年、2034 年
• 皮質類固醇注射
• 聯合類固醇注射
• 全球關節痛注射市場：透明質酸注射細分市場、注射類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 單劑量透明質酸注射
• 多次注射玻尿酸
• 全球關節痛注射市場：富血小板血漿 (PRP) 注射細分、注射劑類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 自體 PRP 注射
• 同種異體 PRP 注射
• 全球關節痛注射市場：胎盤組織基質 (PTM) 注射細分市場、注射類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 羊水注射
• 胎盤細胞注射
• 全球關節痛注射市場：依其他類型注射細分，依注射類型細分，實際及預測，2019-2024 年，2024-2029F，2034F
• 骨髓抽吸濃縮液（BMAC）注射
• 幹細胞注射
• 基因改造細胞注射

第7章 區域和國家分析

• 全球關節痛注射市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 全球關節痛注射市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第 17 章 德國市場

第 18 章 法國市場

第 19 章：義大利市場

第 20 章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第 25 章：加拿大市場

第26章 南美洲市場

第 27 章：巴西市場

第28章 中東市場

第 29 章：非洲市場

第 30 章競爭格局與公司概況

• 關節痛注射市場：競爭格局
• 關節痛注射市場：公司簡介
  • Seikagaku Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Flexion Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • Anika Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

• Abbvie Inc.
• Bioventus Inc.
• Eli Lilly and Company
• Ferring Pharmaceuticals Inc.
• Pfizer Inc.
• Teva Pharmaceutical Industries Limited
• Johnson & Johnson Services Ltd.
• Merck & Co. Inc.
• GlaxoSmithKline plc
• Novartis AG
• AstraZeneca plc
• Roche Holding AG
• Bristol-Myers Squibb Company
• Boehringer Ingelheim International GmbH
• Takeda Pharmaceutical Company Limited

第 32 章 全球競爭基準化分析與儀錶板

第33章 重大併購

第 34 章 近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

• 關節痛注射市場 2029-提供最多新機會的國家
• 關節痛注射市場 2029-提供最多新機會的市場
• 關節痛注射市場 2029-成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第 36 章 附錄

Joint pain injections serve to reduce inflammation and discomfort, typically administered directly into the joint to alleviate pain. Joint pain is a common occurrence, particularly among the elderly or individuals with pre-existing medical conditions or disorders. Conditions such as arthritis, characterized by pain and inflammation, often contribute to joint pain. Joint pain injections offer a non-surgical approach to quickly relieve joint pain and inflammation.

The primary types of injections for joint pain include steroid joint injections, hyaluronic acid injections, platelet-rich plasma (PRP) injections, placental tissue matrix (PTM) injections, and various others. Steroid joint injections, also known as corticosteroid injections, are anti-inflammatory medications used to treat joint pain. They are particularly effective in reducing inflammation in individuals with conditions like rheumatoid arthritis and other forms of inflammatory arthritis. Joint pain injections are applied to various types of joints, including the hip joint, knee and ankle joints, shoulder and elbow joints, facet joints of the spine, and others. These injections are commonly distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

The joint pain injections market research report is one of a series of new reports from The Business Research Company that provides joint pain injections market statistics, including joint pain injections industry global market size, regional shares, competitors with a joint pain injections market share, detailed joint pain injections market segments, market trends and opportunities, and any further data you may need to thrive in the joint pain injections industry. This joint pain injections market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The joint pain injections market size has grown rapidly in recent years. It will grow from $5.6 billion in 2024 to $6.17 billion in 2025 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to increased aging population, arthritis prevalence, global health initiatives, healthcare digitalization, increasing awareness of chronic pain management.

The joint pain injections market size is expected to see rapid growth in the next few years. It will grow to $9.81 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to expansion of telehealth services, personalized pain management, patient education and empowerment, sustainable healthcare practices, nutritional support. Major trends in the forecast period include regenerative medicine, personalized pain management, innovative injection materials, rehabilitation technologies, artificial intelligence ai-enhanced injections.

The increasing prevalence of arthritis and musculoskeletal disorders is expected to drive the growth of the joint pain injections market. Musculoskeletal disorders are the leading cause of disability globally, with low back pain identified as the most common cause of impairment in 160 countries. Patients often seek injections for pain relief and to manage inflammatory conditions. For example, in June 2023, the Australian Institute of Health and Welfare, a government agency in Australia, reported that rheumatoid arthritis accounted for 2.0% of the total disease burden and 16% of the overall burden of disease related to musculoskeletal conditions. In 2022, it resulted in 1,322 deaths, equating to 5.1 deaths per 100,000 people, which represented 0.7% of all deaths. Therefore, the rising prevalence of arthritis and musculoskeletal disorders is driving the joint pain injections market.

The rising incidence of chronic pain is anticipated to drive the growth of the joint pain injections market in the future. Chronic pain is characterized by persistent or long-lasting discomfort that continues for an extended duration, typically defined as lasting at least three to six months or beyond the expected healing time. Joint pain injections are commonly utilized to manage chronic pain, particularly when it is linked to musculoskeletal conditions such as osteoarthritis, rheumatoid arthritis, or other joint-related issues. For example, in September 2022, the World Health Organization (WHO) reported in its 2022 Highlights that there were 41 million deaths, accounting for 74% of all fatalities due to noncommunicable diseases (NCDs) or chronic diseases globally each year. Consequently, the increase in the incidence of chronic pain is propelling the growth of the joint pain injections market.

A prominent trend in the joint pain injections market is the focus on new product development. Major companies in this sector are actively engaged in innovating new products to meet consumer demand and enhance their market position. For instance, Contura International Ltd., a UK-based manufacturer of therapeutic hydrogels, introduced Arthrosamid in September 2021. Arthrosamid, an innovative hydrogel injection for knee osteoarthritis, utilizes non-biodegradable hydrogel technology, providing a potent, long-lasting, secure, and minimally intrusive treatment for knee osteoarthritis pain.

Leading companies in the joint pain injections market are concentrating on developing innovations such as single-injection formulations, which prioritize patient convenience. A single-injection formulation is a type of drug delivery system designed to deliver a specific dose of medication in a single injection, offering sustained therapeutic effects over an extended period without the need for multiple doses. For example, in July 2024, LG Chem Ltd., a chemicals company based in South Korea, introduced Synovian, a new treatment for knee osteoarthritis in China that features a convenient single-injection formulation, making it the first of its kind in the country. The product aims to capture a significant market estimated at around KRW 200 billion (approximately USD 150 million). Developed using proprietary technology, it demonstrates innovation in meeting patient needs, focusing on providing effective relief with minimal administration effort.

In November 2022, Biocon Biologics Limited, a pharmaceutical company based in India, acquired the biosimilars business from Viatris Inc. for $3.33 billion. This acquisition enables Biocon to utilize Viatris' extensive experience and established presence in the global market, improving access to critical therapies for patients around the world. This strategic move is anticipated to enhance its biosimilars portfolio, including Adalimumab BS for subcutaneous injection, which is indicated for immune-related diseases like rheumatoid arthritis. Viatris Inc. is a healthcare company based in the US that offers joint pain medications.

Major companies operating in the joint pain injections market include Seikagaku Corporation, Flexion Therapeutics Inc., Zimmer Biomet Holdings Inc., Sanofi S.A., Anika Therapeutics Inc., Abbvie Inc., Bioventus Inc., Eli Lilly and Company, Ferring Pharmaceuticals Inc., Pfizer Inc., Teva Pharmaceutical Industries Limited, Johnson & Johnson Services Ltd., Merck & Co. Inc., GlaxoSmithKline plc, Novartis AG, AstraZeneca plc, Roche Holding AG, Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Takeda Pharmaceutical Company Limited, Bayer AG, Astellas Pharma Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Ipsen SA, Mallinckrodt Pharmaceuticals Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., Zydus Lifesciences Limited

North America was the largest region in the joint pain injections market in 2024. The regions covered in the joint pain injections market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the joint pain injections market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The joint pain injections market consists of sales of epidural steroid injections, facet joint injections, viscosupplementation injections, corticosteroid injections and hyaluronic acid injections. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Joint Pain Injections Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on joint pain injections market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for joint pain injections ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The joint pain injections market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type Of Injection: Steroid Joint Injection; Hyaluronic Acid Injections; Platelet-Rich Plasma (PRP) Injections; Placental Tissue Matrix (PTM) Injections; Other Type Of Injections
• 2) By Joint Type: Hip Joint; Knee And Ankle; Shoulder And Elbow; Facet Joints Of The Spine; Other Joint Types
• 3) By Distribution channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Subsegments:
• 1) By Steroid Joint Injection: Corticosteroid Injections; Combination Steroid Injections
• 2) By Hyaluronic Acid Injections: Single-Dose Hyaluronic Acid Injections; Multi-Dose Hyaluronic Acid Injections
• 3) By Platelet-Rich Plasma (PRP) Injections: Autologous PRP Injections; Allogeneic PRP Injections
• 4) By Placental Tissue Matrix (PTM) Injections: Amniotic Fluid Injections; Placental Derived Cell Injections
• 5) By Other Types of Injections: Bone Marrow Aspirate Concentrate (BMAC) Injections; Stem Cell Injections; Genetically Engineered Cell Injections
• Companies Mentioned: Seikagaku Corporation; Flexion Therapeutics Inc.; Zimmer Biomet Holdings Inc.; Sanofi S.A.; Anika Therapeutics Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Joint Pain Injections Market Characteristics

3. Joint Pain Injections Market Trends And Strategies

4. Joint Pain Injections Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Joint Pain Injections Growth Analysis And Strategic Analysis Framework

• 5.1. Global Joint Pain Injections PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Joint Pain Injections Market Growth Rate Analysis
• 5.4. Global Joint Pain Injections Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Joint Pain Injections Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Joint Pain Injections Total Addressable Market (TAM)

6. Joint Pain Injections Market Segmentation

• 6.1. Global Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Steroid Joint Injection
• Hyaluronic Acid Injections
• Platelet-Rich Plasma (PRP) Injections
• Placental Tissue Matrix (PTM) Injections
• Other Type Of Injection
• 6.2. Global Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hip Joint
• Knee And Ankle
• Shoulder And Elbow
• Facet Joints Of The Spine
• Other Joint Types
• 6.3. Global Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.4. Global Joint Pain Injections Market, Sub-Segmentation Of Steroid Joint Injection, By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Corticosteroid Injections
• Combination Steroid Injections
• 6.5. Global Joint Pain Injections Market, Sub-Segmentation Of Hyaluronic Acid Injections, By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Dose Hyaluronic Acid Injections
• Multi-Dose Hyaluronic Acid Injections
• 6.6. Global Joint Pain Injections Market, Sub-Segmentation Of Platelet-Rich Plasma (PRP) Injections, By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Autologous PRP Injections
• Allogeneic PRP Injections
• 6.7. Global Joint Pain Injections Market, Sub-Segmentation Of Placental Tissue Matrix (PTM) Injections, By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Amniotic Fluid Injections
• Placental Derived Cell Injections
• 6.8. Global Joint Pain Injections Market, Sub-Segmentation Of Other Types of Injections, By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bone Marrow Aspirate Concentrate (BMAC) Injections
• Stem Cell Injections
• Genetically Engineered Cell Injections

7. Joint Pain Injections Market Regional And Country Analysis

• 7.1. Global Joint Pain Injections Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Joint Pain Injections Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Joint Pain Injections Market

• 8.1. Asia-Pacific Joint Pain Injections Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Joint Pain Injections Market

• 9.1. China Joint Pain Injections Market Overview
• 9.2. China Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Joint Pain Injections Market

• 10.1. India Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Joint Pain Injections Market

• 11.1. Japan Joint Pain Injections Market Overview
• 11.2. Japan Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Joint Pain Injections Market

• 12.1. Australia Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Joint Pain Injections Market

• 13.1. Indonesia Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Joint Pain Injections Market

• 14.1. South Korea Joint Pain Injections Market Overview
• 14.2. South Korea Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Joint Pain Injections Market

• 15.1. Western Europe Joint Pain Injections Market Overview
• 15.2. Western Europe Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Joint Pain Injections Market

• 16.1. UK Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Joint Pain Injections Market

• 17.1. Germany Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Joint Pain Injections Market

• 18.1. France Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Joint Pain Injections Market

• 19.1. Italy Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Joint Pain Injections Market

• 20.1. Spain Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Joint Pain Injections Market

• 21.1. Eastern Europe Joint Pain Injections Market Overview
• 21.2. Eastern Europe Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Joint Pain Injections Market

• 22.1. Russia Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Joint Pain Injections Market

• 23.1. North America Joint Pain Injections Market Overview
• 23.2. North America Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Joint Pain Injections Market

• 24.1. USA Joint Pain Injections Market Overview
• 24.2. USA Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Joint Pain Injections Market

• 25.1. Canada Joint Pain Injections Market Overview
• 25.2. Canada Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Joint Pain Injections Market

• 26.1. South America Joint Pain Injections Market Overview
• 26.2. South America Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Joint Pain Injections Market

• 27.1. Brazil Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Joint Pain Injections Market

• 28.1. Middle East Joint Pain Injections Market Overview
• 28.2. Middle East Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Joint Pain Injections Market

• 29.1. Africa Joint Pain Injections Market Overview
• 29.2. Africa Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Joint Pain Injections Market Competitive Landscape And Company Profiles

• 30.1. Joint Pain Injections Market Competitive Landscape
• 30.2. Joint Pain Injections Market Company Profiles
  • 30.2.1. Seikagaku Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Flexion Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Anika Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Joint Pain Injections Market Other Major And Innovative Companies

• 31.1. Abbvie Inc.
• 31.2. Bioventus Inc.
• 31.3. Eli Lilly and Company
• 31.4. Ferring Pharmaceuticals Inc.
• 31.5. Pfizer Inc.
• 31.6. Teva Pharmaceutical Industries Limited
• 31.7. Johnson & Johnson Services Ltd.
• 31.8. Merck & Co. Inc.
• 31.9. GlaxoSmithKline plc
• 31.10. Novartis AG
• 31.11. AstraZeneca plc
• 31.12. Roche Holding AG
• 31.13. Bristol-Myers Squibb Company
• 31.14. Boehringer Ingelheim International GmbH
• 31.15. Takeda Pharmaceutical Company Limited

32. Global Joint Pain Injections Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Joint Pain Injections Market

34. Recent Developments In The Joint Pain Injections Market

35. Joint Pain Injections Market High Potential Countries, Segments and Strategies

• 35.1 Joint Pain Injections Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Joint Pain Injections Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Joint Pain Injections Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer